SCHEMBL3411038

SCHEMBL3411038

COc1cc(C)c(S(=O)(=O)N2CCCCC2COCC(=O)NCC2CCC(c3ccccc3)(N3CCOCC3)CC2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
FAAH O00519 1/20 0.36
ACHE P22303 1/20 0.36
NPC1 O15118 2/20 0.36
PTGIR P43119 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
THRB P10828 1/20 0.35
NAPEPLD Q6IQ20 1/20 0.34
MAPT P10636 1/20 0.34
GAA P10253 1/20 0.34
NPY1R P25929 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413016 0.98 RAB9A (0.39) RAB9AFAAHACHENPC1PTGIR
SCHEMBL3405474 0.90 ATM (0.39) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL3411158 0.88 ATM (0.37) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL3412336 0.87 FAAH (0.39) RAB9AFAAHACHENPC1PTGIR
SCHEMBL3410511 0.85 NPY1R (0.38) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL3406342 0.84 RAB9A (0.39) RAB9ANPC1SMN1; SMN2LMNAALDH1A1
SCHEMBL493010 0.83 PTGIR (0.37) RAB9AFAAHACHENPC1PTGIR
SCHEMBL3413034 0.82 BDKRB1 (0.35) RAB9ANPC1NPY1RKCNH2
SCHEMBL3407985 0.81 BDKRB1 (0.49)
SCHEMBL3407479 0.81 SMN1; SMN2 (0.38) FAAHACHESMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US claimed
EP-2257527-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-12-08 EP disclosed
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed
WO-2009115257-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253669-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 RAB9A 2485/4885FAAH 438/4885ACHE 3955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.